The 63rd World Health Assembly concluded at the end of last week, with delegates adopting proposed resolutions on a number of global health issues, including:
Counterfeit medical products
The World Health Assembly resolved that the WHO should convene an intergovernmental working group on counterfeit medical products, participation in which is to be open to all Member States.
This group will examine WHO’s:
- role in ensuring availability of good-quality, safe, efficacious and affordable medicines
- relationship with the International Medical Products Anti-Counterfeiting Taskforce (IMPACT)
- role in prevention and control of substandard/spurious/falsely-labelled/falsified/counterfeit medical products.
The group’s mandate is to focus on public health issues only – IP and trade issues will not be considered. Recommendations will be presented at the 64th World Health Assembly, in 2011.
Treatment and prevention of pneumonia
WHO Member States adopted a resolution on the treatment and prevention of pneumonia — the number one killer of children under five years globally. The resolution makes it clear that intensified efforts to address pneumonia are imperative if the achievement of Millennium Development Goal 4 is to be achieved.
On the topic of polio eradication, Member States welcomed the new Global Polio Eradication Initiative (GPEI) Strategic Plan 2010-2012, developed over the past 24 months at the request of the Assembly. The delegates expressed serious concern that insufficient financing for the new Plan is compromising its full implementation, as US$1.3 billion is still needed for the period 2010-2012.
Global eradication of measles
Member States endorsed a series of interim targets set for 2015 as milestones towards the eventual global eradication of measles. Success in achieving the measles 2015 targets is a key issue if the Millennium Development Goal 4 to reduce child mortality is to be reached.
Public health, innovation and intellectual property: global strategy and plan for action
A new consultative working group will examine the way to take this work forward and is expected to report back to the 65th Health Assembly in 2012.
Discussions on other global health issues at the 63rd WHA were summarized in a previous Patients and Patents posting.
Additional information on the resolutions is available at the World Health Organization site.
Filed under: Commentary on news & events, World Health Organization | Tagged: access to medicines, Counterfeit drugs, counterfeit medicines, global health, Innovation, measles, Millenium Development Goals, neglected diseases, pneumonia, polio, Public health, World Health Assembly, World Health Organization | Leave a Comment »